NTC Launches Imperial, the new eye drops product line on THE PATIENT'S SIDE

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

NTC-Pharma-Eye-Drops

More Like This

PR Newswire associated0

NTC gives long term consistency to its ophtha portfolio with another MDR CE Certificate approval

PR Newswire associated0

NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis

PR Newswire associated0

NTC Ophthalmics lberica: Young ophthalmologists square in Zahara Los Atunes

Business Wire logo

Novaliq and Laboratoires Théa Announce Partnership and EU Approval for Vevizye® (Ciclosporin 0.1% Eye Drops Solution)

Business Wire logo

Nordic Pharma Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Completes Acquisition of Visant Medical to Launch Novel Therapy for Dry Eye Disease in the United States

ACCESSWIRE logo

Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management

PR Newswire associated0

Endo Launches Enhanced TruDelivery® Ready-to-Use Product Line and Platform

Novaliq Receives Positive CHMP Opinion for Vevizye® in Dry Eye Disease (Graphic: Business Wire)

Novaliq Receives Positive CHMP Opinion for Vevizye® in Dry Eye Disease